Objective: To review the physiologic effects of carbon dioxide (CO 2 ) pneumoperitoneum in the morbidly obese. Summary Background Data: The number of laparoscopic bariatric operations performed in the United States has increased dramatically over the past several years. Laparoscopic bariatric surgery requires abdominal insufflation with CO 2 and an increase in the intraabdominal pressure up to 15 mm Hg. Many studies have demonstrated the adverse consequences of pneumoperitoneum; however, few studies have examined the physiologic effects of pneumoperitoneum in the morbidly obese. Methods: A MEDLINE search from 1994 to 2003 was performed using the key words morbid obesity, laparoscopy, bariatric surgery, pneumoperitoneum, and gastric bypass. The authors reviewed papers evaluating the physiologic effects of pneumoperitoneum in morbidly obese subjects undergoing laparoscopy. The topics examined included alteration in acid-base balance, hemodynamics, femoral venous flow, and hepatic, renal, and cardiorespiratory function. Results: Physiologically, morbidly obese patients have a higher intraabdominal pressure at 2 to 3 times that of nonobese patients. The adverse consequences of pneumoperitoneum in morbidly obese patients are similar to those observed in nonobese patients. Laparoscopy in the obese can lead to systemic absorption of CO 2 and increased requirements for CO 2 elimination. The increased intraabdominal pressure enhances venous stasis, reduces intraoperative portal venous blood flow, decreases intraoperative urinary output, lowers respiratory compliance, increases airway pressure, and impairs cardiac function. Intraoperative management to minimize the adverse changes include appropriate ventilatory adjustments to avoid hypercapnia and acidosis, the use of sequential compression devices to minimizes venous stasis, and optimize intravascular volume to minimize the effects of increased intraabdominal pressure on renal and cardiac function. Conclusions: Morbidly obese patients undergoing laparoscopic bariatric surgery are at risk for intraoperative complications relating to the use of CO 2 pneumoperitoneum. Surgeons performing laparoscopic bariatric surgery should understand the physiologic effects of CO 2 pneumoperitoneum in the morbidly obese and make appropriate intraoperative adjustments to minimize the adverse changes. (Ann Surg 2005;241: 219 -226) 
O
besity is now considered an epidemic in the United States. According to a study from the Center for Disease Control and Prevention, 30.5% of Americans are considered obese with a body mass index (BMI) greater than 30 kg/m 2 , and 4.7% of Americans are considered morbidly obese (BMI Ͼ 40). 1 Obesity is also affecting children in the United States. The prevalence of overweight among children and adolescents has increased from 10% in 1971 to 1974 to 31% in 1999 to 2000. 2 Obesity contributes to the development of many medical conditions and can also lead to premature death. 3 Surgical therapy is an effective sustained means of weight loss for the treatment of morbid obesity according to the 1991 National Institutes of Health Consensus Conference. 4 Rouxen-Y gastric bypass (GBP) is currently the most commonly performed bariatric operation in the United States. With the introduction of laparoscopic bariatric surgery in 1994, there has been a tremendous interest by surgeons to incorporate bariatric surgery into their practice. 5 Therefore, it is important for surgeons performing laparoscopic bariatric surgery to understand the fundamental differences between the laparoscopic versus open operation and the possible adverse consequences of pneumoperitoneum in the morbidly obese.
The fundamental differences between laparoscopic and open approaches to bariatric surgery are the methods of access and exposure. Surgical access is generally obtained through an upper midline incision in open bariatric surgery and through five abdominal trocars in laparoscopic bariatric surgery. Surgical exposure of the operative field is commonly performed using abdominal wall retractors in open surgery compared with carbon dioxide (CO 2 ) pneumoperitoneum in laparoscopic surgery. Pneumoperitoneum with CO 2 has been used in clinical practice since the introduction of laparoscopic cholecystectomy in the late 1980s. The physiologic effects of pneumoperitoneum include 1) systemic absorption of CO 2 and 2) hemodynamic and physiologic alteration in a variety of organs due to the increased intraabdominal pressure. CO 2 absorption across the peritoneal surface and into the systemic circulation can result in hypercarbia and eventual systemic acidosis. The increased intraabdominal pressure during pneumoperitoneum has been shown in nonobese subjects to result in hemodynamic alteration and changes in femoral venous flow and renal, hepatic, and cardiorespiratory function. 6 -9 Few studies have examined the effects of CO 2 pneumoperitoneum in the morbidly obese. In addition, laparoscopic bariatric surgery, particularly laparoscopic GBP, is a complex operation often associated with a longer operative time than other commonly performed laparoscopic procedures. A longer operative time during laparoscopic GBP translates to longer exposure of the host to the adverse physiologic effects of pneumoperitoneum (Fig. 1) . Therefore, surgeons performing laparoscopy in morbidly obese patients should understand the basic physiologic changes occurring during pneumoperitoneum, recognize the clinical changes, and make appropriate intraoperative adjustments to minimize the adverse changes. Table 1 summarizes the effects of pneumoperitoneum on acid-base balance and CO 2 elimination. Pneumoperitoneum can result in systemic absorption of CO 2 and alteration of acid-base balance. Absorption of CO 2 across the peritoneum is normally eliminated through the lungs because of its high aqueous solubility and diffusibility. If intraoperative ventilation is impaired, CO 2 absorption can result in hypercapnia and acidosis. 10 Hypercapnia can cause cardiac arrhythmias, vasoconstriction of the pulmonary vessels, and a mixed response in cardiac function. Acidosis associated with hypercapnia has a depressive effect on myocardial contractility, whereas hypercapnia can stimulate the autonomic nervous system leading to tachycardia and increased myocardial contractility. To prevent hypercapnia, close intraoperative monitoring of end-tidal CO 2 (ETCO 2 ) or arterial partial pressure of CO 2 (PaCO 2 ) is therefore essential. Although ETCO 2 level is an easily accessible monitoring parameter, it often underestimates the true level of PaCO 2 . 11 In patients undergoing laparoscopic adjustable gastric banding, Demiroluk et al 12 reported an increase in PaCO 2 levels from 34 mm Hg at baseline to 42 mm Hg after abdominal insufflation. In a study of laparoscopic versus open GBP, ETCO 2 levels were found to increase by 14% of baseline (from 35 mm Hg to 40 mm Hg), and PaCO 2 levels increased by 10% of baseline (from 38 mm Hg to 42 mm Hg) during laparoscopic GBP. 13 Although ETCO 2 and PaCO 2 levels increased during laparoscopy, these levels are still considered as normocapnia because appropriate ventilatory adjustments were performed. 13 During pneumoperitoneum, appropriate ventilatory changes should be performed to eliminate the increased CO 2 load and prevent systemic acidosis. Ventilatory changes consist of increasing the minute ventilation. Dumont et al 14 reported that minute ventilation increased by 21% to limit the rise in ETCO 2 in patients undergoing laparoscopic gastroplasty. In a study of patients undergoing laparoscopic GBP, ventilatory adjustments were performed by increasing the respiratory rate by 25% and minute ventilation by 21% to counteract the increase in CO 2 load and prevent intraoperative acidosis. 13 Elimination of the increased CO 2 load is performed primarily through the lungs. The total volume of exhaled CO 2 (VCO 2 ) during pneumoperitoneum is therefore an indirect method to quantify the amount of CO 2 absorbed during 13 Overall, absorption and excretion of CO 2 in morbidly obese subjects appear to be similar to that of nonobese subjects.
EFFECTS OF CARBON DIOXIDE ABSORPTION DURING PNEUMOPERITONEUM

EFFECTS OF INCREASED INTRAABDOMINAL PRESSURE DURING PNEUMOPERITONEUM
Pneumoperitoneum results in a state of acutely elevated intraabdominal pressure. Similar to nonobese subjects, the intraabdominal pressure during laparoscopy of the morbidly obese is set at 15 mm Hg to provide adequate visualization and exposure of the operative field. The normal intraabdominal pressure of nonobese individuals is 5 mm Hg or less. 16 In contrast, morbidly obese patients have a chronically elevated intraabdominal pressure at 9 to 10 mm Hg. 17 This section discusses the physiologic effects of increased intraabdominal pressure during pneumoperitoneum on femoral venous flow and renal, hepatic, and cardiorespiratory function.
Hemodynamic Changes and Cardiac Function
Abdominal insufflation has been shown to alter mean arterial pressure and heart rate ( Table 2) . Heart rate and mean arterial blood pressure commonly increase during laparoscopy. 18, 19 In a study of morbidly obese patients, heart rate and mean arterial pressure increased during both laparoscopic and open GBP and remained elevated throughout the operation. 20 Comparing between obese and nonobese individuals, Fried et al 21 reported that heart rate increased after pneumoperitoneum in both nonobese and obese individuals; however, obese individuals had a more pronounced increase in the heart rate level.
The hemodynamic effects of pneumoperitoneum on cardiac function have been extensively examined in nonobese individuals. Several investigators have demonstrated a reduction in cardiac output during pneumoperitoneum, [22] [23] whereas others 24 -25 26 reported that cardiac output was depressed during pneumoperitoneum but not during the abdominal wall lifting technique and suggested that the increased intraabdominal pressure during pneumoperitoneum is the main factor responsible for alteration of cardiac function.
Few studies have examined the effects of pneumoperitoneum on cardiac function in the obese. Fried et al 21 compared cardiac function of 6 morbidly obese individuals with 6 normal body weight subjects; morbidly obese subjects had a 12% increase in cardiac output after abdominal insufflation. Using Swan-Ganz catheterization, Nguyen et al 20 reported a decrease in cardiac output and stroke volume upon abdominal insufflation by 6% and 8% of baseline, respectively, during laparoscopic GBP. In contrast to the results observed in the nonobese, studies in morbidly obese subjects demonstrated minimal cardiac depression with initiation of pneumoperitoneum. We hypothesized that the cardiac dysfunction during pneumoperitoneum is minimized or better tolerated in morbidly obese patients with an intrinsically elevated intraabdominal pressure at 9 to 10 mm Hg compared with nonobese patients with an intrinsic intraabdominal pressure of less than 5 mm Hg.
Many factors influence cardiac function including preload, afterload, cardiac contractility, heart rate, and myocardial compliance. Hypovolemia reduces the preload and hence reduces cardiac output. Therefore, a euvolemic preoperative volume status is very important to minimize any cardiac depression associated with pneumoperitoneum. Measurement of filling pressures is the most accurate method for estimation of intravascular volume; however, cardiac filling pressure can be falsely elevated during pneumoperitoneum. The increased Factors specific to laparoscopy that can affect intraoperative cardiac function include increased intraabdominal pressure, reverse Trendelenburg positioning, and hypercarbia. Hypercarbia is normally avoided during laparoscopy because of appropriate ventilatory adjustments. In most clinical studies, a moderate rise in PaCO 2 levels (Ͻ45 mm Hg) should not contribute to cardiac impairment. In addition, reverse Trendelenburg positioning is also not a major factor in alteration of hemodynamic status. 27 The increased intraabdominal pressure is the main factor that may account for cardiac depression. The mechanisms for reduction in cardiac output after abdominal insufflation include an increase in afterload and a decrease in preload by impeding venous return. Declan Fleming et al 28 reported that the afterload, as measured by systemic vascular resistance, increased by 25% of baseline after abdominal insufflation and decreased with desufflation. Nguyen et al 20 noted that open GBP was not associated with any alteration in the systemic vascular resistance while laparoscopic GBP resulted in an immediate increase in the systemic vascular resistance by 34% of baseline upon insufflation and returned to baseline value within 1.5 hours after initiation of pneumoperitoneum. The timing for the increase in systemic vascular resistance correlated with the reduction in cardiac output and stroke volume. 20 The results from these studies suggest that an increase in the systemic vascular resistance is the primary event leading to a reduction in cardiac output. In addition, cardiac depression during pneumoperitoneum is often transient as the body compensates for the altered physiology. Zuckerman and Heneghan 29 reported that reduction in cardiac index occurred immediately after abdominal insufflation during laparoscopic cholecystectomy but returned to baseline levels within 10 to 15 minutes after abdominal insufflation. Similar results were observed in morbidly obese subjects; cardiac output levels recovered after a transient depression at 2.5 hours after abdominal insufflation during laparoscopic GBP. Table 3 summarizes the effects of pneumoperitoneum on intraoperative portal venous flow and postoperative changes in liver enzymes. In animal and human studies, the increased intraabdominal pressure at 15 mm Hg has been shown to reduce portal venous flow. 30 In a clinical study of laparoscopic cholecystectomy, Jakimowics et al 6 reported a 53% reduction in portal blood flow with abdominal insufflation to 14 mm Hg. A reduction in portal venous blood flow during pneumoperitoneum may lead to hepatic hypoperfusion and acute hepatocyte injury. Portal hypoperfusion can lead to transient elevation of liver enzymes. Halevy et al 31 reported transient increases in the level of hepatic transaminases (ALT and AST) after laparoscopic cholecystectomy, which returned to baseline by 72 hours postoperatively. Understanding the effect of pneumoperitoneum on portal venous flow is particularly important in the morbidly obese as these patients often have preexisting liver disease. Gholam et al 32 noted that 84% of subjects who underwent Roux-en-Y GBP had steatosis, and Spaulding et al 33 reported that there is a 56% prevalence of nonalcoholic steatohepatitis in morbidly obese subjects.
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Hepatic Function
Few studies have examined the effects of pneumoperitoneum on hepatic function in the morbidly obese. Transient elevation of hepatic transaminase levels (ALT and AST) after laparoscopic and open GBP have been reported. 34, 35 The transaminase levels after laparoscopic GBP have been shown to increase by 6-fold, peaking at 24 hours postoperatively, and returned to baseline by the third postoperative day. 34 Although a mild increase in hepatic enzymes is not a specific indicator for liver damage, an increase in hepatic transaminase levels exceeding 3 times that of baseline may suggest acute hepatic damage. The mechanisms for alteration of postoperative hepatic function include direct operative trauma to the liver, the use of general anesthetics, and the reduction of portal venous flow during pneumoperitoneum. The operative trauma associated with mechanical retraction of the left lobe of the liver is the primary mechanism for elevation of liver enzymes after open GBP. 35 Certain anesthetic agents, metabolized through the liver, can be hepatotoxic and result in elevation of postoperative hepatic enzymes. Lastly, an acute increase in the intraabdominal pressure during laparoscopy has been shown to decrease portal venous flow, as the normal portal pressure is often less than 10 mm Hg. 6, 30 Although acute elevation of hepatic transaminases were observed after laparoscopic GBP, it was only transient and subsided by the third postoperative day without long-term sequelae. Therefore, pneumoperitoneum in the morbidly obese is considered safe in patients with normal baseline liver function. Further studies are needed to evaluate the safety of pneumoperitoneum in patients with preexisting severe liver dysfunction.
Intraoperative Pulmonary Mechanics
The increased intraabdominal pressure at 15 mm Hg during laparoscopy can adversely affect intraoperative pulmonary mechanics. Pneumoperitoneum in nonobese subjects has been shown to decrease the respiratory compliance and increase airway pressure. 36, 37 The mechanism for these physiologic changes is the increased intraabdominal pressure with cephalad shift of the diaphragm. Table 4 summarizes the effects of pneumoperitoneum on intraoperative respiratory mechanics.
Respiratory compliance consists of both lung and chest wall compliance. In a randomized trial comparing pulmonary mechanics during cholecystectomy performed by an abdominal wall lift method or pneumoperitoneum, Lindgren et al 36 reported higher respiratory compliance during the abdominal lift method than during pneumoperitoneum. Similar findings occurred in morbidly obese subjects. Dumont et al 14 reported a reduction in pulmonary compliance by 31% in patients who underwent laparoscopic gastroplasty. In a study of laparoscopic and open GBP, respiratory compliance decreased by 42% during laparoscopic GBP compared with 29% during open GBP. 13 Reduction in respiratory compliance during open GBP is related to the use of rigid mechanical retractors on the abdominal wall, whereas the reduction in respiratory compliance during laparoscopic GBP is related to the increased intraabdominal pressure.
Increased intraabdominal pressure during laparoscopy also increases the airway pressure. Without ventilatory changes, peak inspiratory pressure (PIP) can increase by 17% to 109% during laparoscopy.
11,14,37 Galizia et al 37 reported a significant increase in PIP in patients who underwent laparoscopic cholecystectomy but no change in PIP in patients who underwent cholecystectomy by the abdominal wall lifting method. In morbidly obese patients who underwent laparoscopic gastroplasty, Dumont et al 14 reported an increase in airway pressure by 17%. Nguyen et al 13 reported no significant change in PIP during open GBP, but PIP levels increased by 12% during laparoscopic GBP. To limit the rise in PIP, ventilatory adjustment is commonly performed by decreasing the tidal volume.
Although pneumoperitoneum alters respiratory compliance and airway pressure, the pulmonary gas exchange is unaffected during laparoscopic cholecystectomy. 15 Similarly, no significant intraoperative changes in the physiologic dead space to tidal volume ratio or the alveolar-arterial oxygen gradient occurred in morbidly obese patients undergoing laparoscopic GBP. 13 Sprung et al 38 also reported no significant change in the alveolar-arterial oxygen gradient, and Demiroluk et al 12 reported no significant difference in PaO 2 levels in morbidly obese patient undergoing laparoscopy.
Renal Function
The increased intraabdominal pressure during laparoscopy has been shown to alter renal function (Table 5) . A reduction in intraoperative urine output has been well documented during laparoscopic operations. 39, 40 In a trial comparing laparoscopic adrenalectomy with gasless laparoscopic adrenalectomy, Nishio et al 39 demonstrated that urine output decreased significantly with abdominal insufflation and improved upon desufflation. In a swine model, McDougall et al 40 demonstrated that the degree of intraoperative oliguria is 41 reported that an acute increase in the intraabdominal pressure to greater than 25 mm Hg resulted in acute renal insufficiency and abdominal decompression caused immediate improvement in renal function. Similar to nonobese subjects, intraoperative urine output in morbidly obese subjects decreased immediately after initiation of pneumoperitoneum during laparoscopic GBP and remained 31% to 64% lower than during open GBP. 42 There are several mechanisms for diminished urine output during laparoscopy. Pneumoperitoneum has a direct pressure effect on the renal cortical blood flow. In a swine model, Chiu et al 8 reported that superficial renal cortical perfusion decreased by 60% with abdominal insufflation and returned to baseline level after desufflation. Pneumoperitoneum also has a direct pressure effect on the renal vasculature, resulting in reduced renal blood flow. In a swine study, Are et al 43 demonstrated that renal blood flow decreased by 36% below baseline as measured by radioactive microspheres. In addition, intraoperative releases of certain hormones such as antidiuretic hormone (ADH), plasma rennin activity, and serum aldosterone may diminish urine output. ADH facilitates water reabsorption in the distal tubules and concentrates the urine. Ortega et al 44 reported a precipitous rise in ADH concentrations during laparoscopic cholecystectomy, which was not observed during open cholecystectomy. In a study of morbidly obese subjects, Nguyen et al 42 reported that levels of ADH, plasma rennin activity, and aldosterone significantly increased during laparoscopic GBP.
Despite the intraoperative oliguria, pneumoperitoneum at 15 mm Hg is considered clinically safe. Nishio et al 39 reported no changes in serum creatinine after laparoscopic adrenalectomy when compared with gasless laparoscopic adrenalectomy. In a study of morbidly obese subjects, no significant changes in blood urea nitrogen or serum creatinine levels were observed in the perioperative period after laparoscopic GBP. 42 Additionally, the creatinine clearance measured in patients who underwent laparoscopic GBP was in the normal range both on the first and second postoperative day.
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Venous Stasis
The true incidence of deep venous thrombosis after laparoscopic compared with open operation is unknown; however, some of the factors relating to Virchow's triad (endothelial injury, hypercoagulability, and venous stasis) are altered during laparoscopy. The main factor that is adversely affected during laparoscopy is venous stasis. The increased intraabdominal pressure and reverse Trendelenburg position during laparoscopy have been shown to reduce femoral venous flow. 45, 46 The increased intraabdominal pressure during laparoscopy has a direct compressive effect on the inferior vena cava and iliac veins and decreases lower extremity venous flow. By the force of gravity during reverse Trendelenburg position, the abdominal viscera can also produce a compressive effect on the iliac veins resulting in a decrease in femoral venous flow. In a study of laparoscopic cholecystectomy, Millard et al 45 reported that a combination of pneumoperitoneum and 30°reverse Trendelenburg position decreased peak systolic velocity of the common femoral vein by 42%. Similarly, Ido et al 46 reported that abdominal insufflation reduced femoral vein velocity and the addition of reverse Trendelenburg has an additive effect by further reducing femoral vein velocity.
Development of venous stasis during laparoscopy in morbidly obese subjects has been observed ( Table 6 ). Nguyen et al 47 reported that increased intraabdominal pressure and reverse Trendelenburg positioning are independent factors that resulted in decreased femoral peak systolic velocity. Increased intraabdominal pressure during laparoscopic GBP reduced peak femoral systolic velocity by 43% and increased the femoral cross-sectional area by 52%. 47 By combining pneumoperitoneum with reverse Trendelenburg position, peak femoral systolic velocity was further reduced to 57% of baseline values. 47 The use of sequential compression devices (SCD) during laparoscopy has been shown to reverse the adverse effects of pneumoperitoneum on femoral venous flow in nonobese subjects. 45 The SCD provide a sequential pressure gradient on the lower extremities, which accelerates venous flow and facilitates venous emptying. Millard et al 45 and Schwenk et al 48 reported that the use of SCD during laparoscopic cholecystectomy was effective in reversing the reduced femoral systolic velocity to baseline values. In contrast, the use of SCD in morbidly obese subjects was only partially effective in augmenting the femoral peak systolic velocity. In a study of laparoscopic GBP, a combination of abdominal insufflation and reverse Trendelenburg positioning significantly decreased femoral peak systolic velocity; however, the reduced femoral systolic velocity level was only partially reversed with the use of SCD and was lower than baseline values by 38%. 47 The ineffectiveness of SCD in returning femoral peak systolic velocity to baseline value in morbidly obese patients is attributed to the larger calves and thighs of these individuals. 47 Patients with large calves and thighs may need higher 
PATIENT SELECTION AND INTRAOPERATIVE MANGEMENT
Surgeons performing laparoscopic surgery on the morbidly obese should select appropriate patients based on the above physiologic data. We do not advocate the use of laparoscopic surgery in morbidly obese patients with severe cardiac, pulmonary, hepatic, or renal dysfunction. For example, patients with severe right-sided heart failure, congestive heart failure, moderate/severe coronary artery disease, obesity hypoventilation syndrome, severe liver cirrhosis, or acute renal failure should not undergo laparoscopic bariatric surgery as these patients are at high risk for intraoperative and postoperative complications relating to the use of CO 2 pneumoperitoneum.
Appropriate intraoperative management should be performed to minimize the adverse consequences of laparoscopic surgery in the morbidly obese. The use of sequential compression devices is important to counteract the reduction in femoral systolic velocity during pneumoperitoneum. In addition, surgeons should limit the amount of time the patient is positioned in reverse Trendelenburg as it is an independent factor for development of venous stasis. Basic intraoperative monitoring should include ETCO 2 , urine output, and PaCO 2 levels in selected cases. Morbidly obese patients with cardiac and pulmonary dysfunction undergoing laparoscopic surgery should have more extensive monitoring, including SwanGanz catheterization and radial arterial catheter with routine blood gas measurement. Cardiac depression is common and occurs immediately upon insufflation; however, cardiac output normally recovers by 1.5 hours after insufflation. If cardiac output or cardiac index continues to be depressed in patients with preexisting cardiac dysfunction, surgeons should consider interrupting pneumoperitoneum and/or consider conversion to laparotomy. Ventilatory adjustments should be performed by increasing minute ventilation to eliminate the increased CO 2 load. In general, the respiratory rate is increased to limit the rise in PaCO 2 and the tidal volume is reduced to limit the rise in peak inspiratory pressures. In certain instances, laparoscopy should be interrupted and pneumoperitoneum should be released in order for the anesthesiologist to control excessive hypercapnia. Similarly, oliguria is an expected intraoperative finding but not anuria. Assuming a euvolemic status, intraoperative management for anuria includes evaluation of the Foley catheter for patency and laparoscopic examination of the bladder. If the laparoscopic evaluation demonstrated a collapsed bladder and the Foley catheter is patent, then the diagnosis of anuria should be entertained. Desufflation of the abdomen should be performed until urine output resumes. In cases whereby urine output does not resume with desufflation, conversion to laparotomy should be performed. The role of dopamine to enhance intraoperative urine output is unclear. In a randomized trail evaluating intraoperative urine output of patients undergoing laparoscopic colectomy, Perez et al 49 reported that patients receiving low doses of dopamine had higher urine output compared with patients who did not receive dopamine. Overall, the surgeon must be aware of the physiologic consequences of prolonged laparoscopy, limit the patient's exposure to CO 2 pneumoperitoneum, and make the decision for conversion based on the patients' preoperative physiologic status and response to CO 2 absorption and increased intraabdominal pressure.
CONCLUSION
Altered physiology has been demonstrated during laparoscopy in the morbidly obese patients similar to that of nonobese patients. The two factors during laparoscopy that can result in adverse physiologic changes are absorption of CO 2 and increased intraabdominal pressure. In the morbidly obese, absorption of CO 2 during pneumoperitoneum can lead to an increase in PaCO 2 levels; however, hypercarbia is commonly avoided with appropriate ventilatory changes. Absorption of CO 2 also alters the acid-base balance and increase in CO 2 excretion load. Compared with baseline values, the increased intraabdominal pressure during pneumoperitoneum can reduce femoral venous flow, intraoperative urine output, portal venous flow, respiratory compliance, and cardiac output. Appropriate intraoperative changes should be instituted to minimize these physiologic changes; the use of SCD is important to counteract the reduction in femoral venous flow; increase in intravascular volume is important to minimize intraoperative oliguria, and in certain instances, desufflation is necessary to avoid anuria; appropriate ventilatory changes during pneumoperitoneum include increasing the minute ventilation to minimize the elevated CO 2 load and decreasing the tidal volume to minimize high peak inspiratory pressure. Surgeons should be constantly aware that shortening the operative time is an important factor in reducing the patient's exposure to CO 2 pneumoperitoneum and its adverse consequences. Despite the adverse physiologic changes during pneumoperitoneum, laparoscopic surgery in the morbidly obese is considered safe in patients with normal renal, hepatic, and cardiorespiratory function. Bariatric surgeons should have a thorough understanding of the adverse physiologic effects of pneumoperitoneum and be able to recognize the adverse clinical manifestation and its management.
